{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:12:11Z","timestamp":1784257931941,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jvoice.2020.01.018","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T18:06:27Z","timestamp":1582308387000},"page":"809.e15-809.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Side Effects of Proton Pump Inhibitors: What are Patients\u2019 Concerns?"],"prefix":"10.1016","volume":"35","author":[{"given":"Ana\u00efs","family":"Rameau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Andreadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Belafsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2020.01.018_bib0001","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinternmed.2010.64","article-title":"Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users","volume":"170","author":"Katz","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0002","unstructured":"Gatyas G. IMS Health reports U.S. prescription sales grew 5.1 percent in 2009, to $300.3 Billion. IMS Health. Available at: http:\/\/www.imshealth.com\/portal\/site\/imshealth\/menuitem.a46c6d4df3db4b3d88f611019418c22a\/?vgnextoid=d690a27e9d5b7210VgnVCM100000ed152ca2RCRD&vgnextfmt=default. Accessed 7 October 2010."},{"key":"10.1016\/j.jvoice.2020.01.018_bib0003","unstructured":"GoodRx website. Available at: https:\/\/www.goodrx.com\/drug-guide. Accessed October 13, 2017."},{"key":"10.1016\/j.jvoice.2020.01.018_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0006","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Yu","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0008","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0009","doi-asserted-by":"crossref","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","article-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis","volume":"10","author":"Lambert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1742-1241.2011.02650.x","article-title":"Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis","volume":"65","author":"Trikudanathan","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0011","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B-12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0012","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ki.2012.452","article-title":"Proton-pump inhibitor use is associated with low serum magnesium concentrations","volume":"83","author":"Danziger","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0013","doi-asserted-by":"crossref","first-page":"e015735","DOI":"10.1136\/bmjopen-2016-015735","article-title":"Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans","volume":"7","author":"Xie","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0014","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.gastro.2015.12.016","article-title":"Is proton pump inhibitor use associated with risk of myocardial infarction?","volume":"150","author":"Chan","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0892-1997(02)00097-8","article-title":"Validity and reliability of the reflux symptom index (RSI)","volume":"16","author":"Belafsky","year":"2002","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0016","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0018","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2036.2007.03407.x","article-title":"Systematic review: proton pump inhibitor-associated acute interstitial nephritis","volume":"26","author":"Sierra","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0019","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.2014.74","article-title":"A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use","volume":"86","author":"Blank","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/apt.13800","article-title":"Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors","volume":"44","author":"Martin","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0021","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1136\/bmj.e372","article-title":"Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study","volume":"344","author":"Khalili","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0022","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/j.ajkd.2015.05.012","article-title":"Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study","volume":"66","author":"Kieboom","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168618","article-title":"Use of proton pump inhibitors and the risk of hospitalization for infectious gastroenteritis","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0024","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/ajg.2013.333","article-title":"Proton pump inhibitors and risk for recurrent Clostridium difficile infection among in patients","volume":"108","author":"Freedberg","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0026","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials","volume":"374","author":"O'Donoghue","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0027","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0028","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5009\/gnl16352","article-title":"Pantoprazole does not reduce the antiplatelet effect of clopidogrel: a randomized controlled trial in Korea","volume":"11","author":"Choi","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0029","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2036.2010.04284.x","article-title":"Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia","volume":"31","author":"Johnstone","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/ecp.12.20","article-title":"Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis","volume":"5","author":"Giuliano","year":"2012","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0031","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","article-title":"Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a cross-over trial","volume":"149","author":"Freedberg","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0032","doi-asserted-by":"crossref","first-page":"i5813","DOI":"10.1136\/bmj.i5813","article-title":"Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study","volume":"355","author":"Othman","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0033","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrgastro.2016.44","article-title":"Therapy: risks associated with chronic PPI use - signal or noise?","volume":"13","author":"Kia","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0034","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12916-017-0804-x","article-title":"When is proton pump inhibitor use appropriate?","volume":"15","author":"Yadlapati","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0035","first-page":"477","article-title":"The indications, applications, and risks of proton pump inhibitors","volume":"113","author":"M\u00f6ssner","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0036","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00228-017-2256-9","article-title":"Correlation between proton pump inhibitors and risk of pyogenic liver abscess","volume":"73","author":"Lin","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0037","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fphar.2017.00481","article-title":"Correlation of proton pump inhibitors with pulmonary tuberculosis: a case-control study in Taiwan","volume":"8","author":"Cheng","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0038","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000455008","article-title":"Gastric acid suppression is associated with an increased risk of adverse outcomes in inflammatory bowel disease","volume":"95","author":"Shah","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0039","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1572-0241.2003.07665.x","article-title":"Step-down from multiple-to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs","volume":"98","author":"Inadomi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","article-title":"Effectiveness of proton pump inhibitors in non erosive reflux disease","volume":"2","author":"Dean","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0041","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mlg.0000192173.00498.ba","article-title":"Treatment of chronic posterior laryngitis with esomeprazole","volume":"116","author":"Vaezi","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0042","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1378\/chest.12-1788","article-title":"Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease","volume":"143","author":"Kahrilas","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.15-1496","article-title":"Treatment of unexplained chronic cough: CHEST Guideline and Expert Panel Report","volume":"149","author":"Gibson","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0044","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/000313481408001027","article-title":"Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval","volume":"80","author":"Reynolds","year":"2014","journal-title":"Am Surg"},{"key":"10.1016\/j.jvoice.2020.01.018_bib0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/000313481408001124","article-title":"Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study","volume":"80","author":"Bell","year":"2014","journal-title":"Am Surg"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719305272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719305272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:37:40Z","timestamp":1760211460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199719305272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0892199719305272"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2020.01.018","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side Effects of Proton Pump Inhibitors: What are Patients\u2019 Concerns?","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2020.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The Voice Foundation.","name":"copyright","label":"Copyright"}]}}